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Abstract
Background and objective: Intravenous regional anesthesia (IVRA) for upper limb surgeries with 
traditional high dose of lidocaine can lead to life threatening side effects. In order to avoid these 
potential life threatening side effects, many modiﬁ ed techniques of IVRA have been attempted 
by using a low dose of lidocaine, muscle relaxant and opioid.
Method: The present study is carried out in sixty unpremedicated ASA Class 1 and 2 patients to 
compare the sensory and motor characteristics, cardio-respiratory parameters and side-effects 
during intra-operative and post-tourniquet deﬂ ation period between the patients who received 
40 mL of 0.5% lidocaine alone (n = 30) and those who received a combination of 40 mL of 0.25% 
lidocaine with 0.05 mg fentanyl and 0.5 mg vecuronium (n = 30) in IVRA for upper limb orthopedic 
surgeries. The results were analyzed for statistical signiﬁ cance using a paired student t test.
Results: The difference between the two groups regarding the mean time of onset and complete 
sensory and motor block was statistically signiﬁ cant. But 15 minutes after the injection of 
anesthetic solution, there was complete sensory and motor block in both groups.  
Conclusion: Although the short delay observed in the onset and attainment of complete sensory 
and motor block may theoretically delay the start of surgery for 10-15 minutes but clinically that 
time will be spent in the preparation of surgical ﬁ eld.  So this combination can be used safely and 
effectively in intravenous regional anesthesia for upper limb orthopedic surgeries with reduced 
chance of local anesthetic toxicity.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
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Introduction
In this fast moving world, the number of road trafﬁ c acci-
dents increases and so does the number of patients with 
upper limb trauma coming for various orthopedic surgical 
procedures. These patients often present a full stomach 
and, in addition, may have co-existing diseases, which make 
general anesthesia hazardous. The brachial plexus block can 
be employed for such upper limb orthopedic surgeries, but 
it requires technical skill. Furthermore, complications like 
pneumothorax, inadvertent intravascular injection or injury 
to nerves may occur. The technique has other problems like 
time consumption, delayed onset of analgesia and a chance of 
incomplete analgesia. Thus, a simple and effective technique 
like intravenous regional anesthesia (IVRA) or Bier’s block can 
be an alternative for upper limb surgeries 1.
Traditionally, lidocaine is used as 0.5% solution at the dose 
of 3 mg.kg-1 in IVRA for effective anesthesia during upper 
limb surgeries 2. However, at this high dose, life threatening 
side effects such as convulsions, coma, cardio-respiratory 
depression and even cardiac arrest can occur due to acciden-
tal release of tourniquet during the procedure or deliberate 
release of tourniquet at the end of the procedure. In order 
to avoid these potential life threatening side effects, many 
modiﬁ ed techniques of IVRA have been attempted by using 
a low dose of lidocaine, muscle relaxant and opioid.
Given this background, the present study was carried out 
to evaluate the usefulness of addition of fentanyl (0.05 mg) 
and vecuronium (0.5 mg) to 0.25% lidocaine and to compare 
it with 0.5% lidocaine alone in intravenous regional anesthesia 
for upper limb orthopedic surgeries.
Methods
The institutional ethical committee approved the study 
and researchers obtained written informed consent from 
all patients. 
This study was a randomized, prospective, comparati-
ve study. The study population consisted of sixty patients 
aged between 18 and 60 years belonging to ASA Class 1 and 
2 scheduled for elective upper limb orthopedic surgeries. 
Patients with history of allergy to local anesthetics, highly 
nervous and uncooperative patients, patients with crush 
injury, open wounds, infection and cellulitis of the operative 
limb, patients with history of epilepsy, peripheral arterial 
disease, sickle cell disease, arteriovenous malformation and 
pregnancy were excluded from this study. Patients were 
randomly allocated into two groups of thirty each.
Group A (n = 30): received 40 mL of 0.5% lidocaine 
alone
Group B (n = 30): received 40 mL of 0.25% lidocaine with 
0.05 mg fentanyl and 0.5 mg vecuronium.
A thorough preoperative evaluation was done and the 
patients were kept nil per oral overnight. We explained the 
procedure to ensure good cooperation. To the extent possi-
ble, we chose cases where the surgery was expected to be 
over before the maximum tourniquet time of the upper limb 
(lower than 90 minutes). None of the patients in this study 
received any premedication.
The patients were placed in supine position on a tiltable 
operation table. The intravenous line was secured on the 
non-operating upper limb with 20-gauge intravenous can-
nula for infusion of intravenous ﬂ uids. The patients were 
connected to standard monitors that included continuous 
electrocardiogram, pulse oximetry, and non-invasive blood 
pressure monitor. The baseline values were recorded. All 
the necessary equipment and emergency drugs were kept 
ready for resuscitation, in order to cope with any toxic and 
untoward reactions occurring during the procedure.
The venipuncture was done with 20-gauge intravenous 
cannula in the operative limb. After venipuncture, we per-
formed exsanguination of the operative limb by elevating the 
limb above the body for two to three minutes and applied 
an Esmarch’s bandage starting from the tip of the ﬁ ngers 
till the upper arm, where we applied the tourniquet, with 
due care for the intravenous cannula. We achieved vascular 
occlusion by application of double pneumatic tourniquet. We 
noted the time of inﬂ ation of proximal tourniquet. Before 
inﬂ ating distal tourniquet, we injected the local anesthetic 
drug into the operative limb through the 20-gauge intrave-
nous cannula. The drug was injected slowly over 45 seconds 
to prevent leakage of the drug beyond the tourniquet. We 
inﬂ ated the distal tourniquet 2-3 minutes after the injec-
tion of the drug. After the inﬂ ation of distal tourniquet, the 
proximal tourniquet was deﬂ ated. 
We assessed sensory and motor characteristics during the 
intra-operative and post tourniquet deﬂ ation period based 
on the following scale.
a.Sensory loss: We used a 0-2 scale to assess the sensory 
loss. 
  0 = Sharp
  1 = Touch only (cannot appreciate pinprick)
  2 = Cannot feel touch
b.  Motor loss: We used a 0-3 scale to assess motor block. 
  0 = Ability to move the wrist against resistance
  1 = Inability to move the wrist against resistance
  2 = Inability to move the wrist and elbow against 
resistance
  3 = Inability to move the arm
The time at which patients were unable to perceive a 
pinprick (that is, sensory loss score 1) after the drug injection 
was considered as the time of onset of sensory loss and the 
time at which the patients were unable to perceive touch 
(that is, sensory loss score 2) after the drug injection was 
considered as the time of complete loss of sensation. The 
time at which patients were unable to move their wrist 
against resistance (that is, motor loss score 1) after the drug 
injection was considered as the time of onset of motor loss 
and the time at which patients were unable to move their 
arm (that is, motor loss score 3) after the injection of drug 
was considered as the time of complete loss of motor power. 
The tourniquet was released after surgery was over and, if 
surgery was completed in less than twenty minutes after 
the drug injection, the tourniquet was kept for a minimum 
period of twenty minutes. Before releasing the distal tour-
niquet, we noted duration of surgery and tourniquet time. 
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We studied sensory and motor characteristics in the post-
distal tourniquet deﬂ ation period. We noted the time at 
which full sensation and full motor power returned (period 
of post-operative analgesia). The time from the release of 
distal tourniquet to the appearance of a sharp pain at the 
surgical site was considered as the time of return of full 
sensation. The time from the release of distal tourniquet 
to the time at which patients were able to move the wrist 
against resistance (that is, motor loss score 0) was considered 
as the time of return of full motor power. 
The patients were observed for changes in pulse rate, 
blood pressure (systolic and diastolic), respiratory rate, 
oxygen saturation and electrocardiogram and also for side 
effects such as nausea, giddiness, diplopia and tourniquet 
pain during the intra-operative period and for 30 minutes 
after release of distal tourniquet.
The sample size for the study was based on a pilot study 
of 10 patients. The outcome of the pilot study indicated that 
a sample size of 30 in each group would give enough power 
of more than 85%. However, the results of the pilot study 
were not included in the results of the main study. Results 
were expressed as mean ± SD unless indicated otherwise. 
The results were analyzed for statistical signiﬁ cance using 
paired student t-test. Differences were considered to be 
statistically signiﬁ cant when P value was < 0.05.
Result 
Both groups were statistically comparable with respect to 
demographic variables like age, sex and weight (Table 1). 
The mean tourniquet time was comparable in Groups A and 
B (54 ± 4 min and 55 ± 3 min, respectively) (Table 2). The 
mean time of onset of sensory loss in Group B (6.14 ± 0.78 
minutes) was signiﬁ cantly longer than in Group A (2.22 ± 
0.75 minutes); mean time of complete loss of sensation was 
signiﬁ cantly longer in Group B (12.25 ± 0.92 minutes) than 
in Group A (7.12 ± 0.75 minutes) (Table 2). The mean time 
of onset of motor block in Group B (8.35 ± 1.16 minutes) was 
longer than in Group A (4.17 ± 0.74 minutes); mean time of 
complete motor block in Group B (15.65 ± 0.94 minutes) was 
longer than in Group A (10.57 ± 0.81 minutes) (Table 2). There 
was no statistically signiﬁ cant difference between two groups 
with regards to the time of return of full motor power and 
the time of return of full sensation after deﬂ ation of distal 
tourniquet (Table 2). 
No side effect was reported in the intra-operative period 
in either of the groups except that tourniquet pain was re-
ported in two patients in Group A and none in Group B, but it 
was not statistically signiﬁ cant (Table 3). In post tourniquet 
deﬂ ation period, giddiness occurred in ten patients in Group 
A while none in Group B patients (P < 0.05, signiﬁ cant) and 
nausea occurred in one patient in Group B while none in 
Group A (statistically insigniﬁ cant) (Table 3). There were 
no signiﬁ cant changes in cardio-respiratory parameters in 
either group.
Discussion
In this study, the difference between the two groups re-
garding the mean time of onset and complete sensory and 
motor block was statistically signiﬁ cant (P < 0.05). However, 
within ﬁ fteen minutes of anesthetic solution injection, there 
was complete sensory and motor block in both groups. Thus, 
the quality of anesthesia was comparable in both groups at 
ﬁ fteen minutes after injection of anesthetic solution. This 
roughly coincides with the usual time of start of surgery, 
Table 1  Demographic variables.
Variables Group A Group B p value
Age (years) 38.8 43.6 NS
Male: Female 
(n) 
24:6 20:10 NS
Weight (Kg) 52.6 56.8 NS
n: Number, NS: Not signiﬁ cant.
Table 2  Sensory and motor characteristics.
Variables Group A Group B p value
Time of onset of 
sensory loss (min)
2.22 ± 0.75 6.14 ± 0.78 0.0231
Time of complete 
loss of sensation 
(min)
7.12 ± 0.75 12.25 ± 0.92 0.0214
Time of onset of 
motor block (min)
4.17 ± 0.74 8.35 ± 1.16 0.0315
Time of complete 
motor block (min)
10.57 ± 0.81 15.65 ± 0.94 0.0354
Time of return of 
full motor power 
after release of 
tourniquet (min)
7.64 ± 0.83 7.48 ± 0.80 0.1245 NS
Time of return 
of full sensation 
after release of 
tourniquet (min)
11.93 ± 0.87 12.23 ± 0.73 0.0821 NS
Values are given as mean ±SD, NS: Not signiﬁ cant.
Table 3  Incidence of side effects.
Variables Group A Group B p value
Intraoperative 
period
   Tourniquet pain 
   (Y/N)        
Post-tourniquet 
deﬂ ation
   Nausea  (Y/N) 
   Diplopia (Y/N)
   Giddiness (Y/N)
2/30
0/30
0/30
10/30
0/30
1/30
0/30
0/30
0.0950   NS
 0.0811   NS
 NS
0.0386
Y/N: Yes/No, NS: Not signiﬁ cant.
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after anesthetizing the patient. A similar study conducted 
by Sztark et al. 2 where pancuronium was used instead of 
vecuronium had also shown signiﬁ cant difference in the time 
of onset and complete sensory and motor block between two 
groups but there was no difference between the two groups 
twenty minutes after the injection of anesthetic solution 2. 
Abdulla and Fadhil had conducted a study comparing lidocai-
ne (100 mg) alone with a combination of lidocaine (100 mg), 
fentanyl (50 μg) and combination of lidocaine (100 mg), 
fentanyl (50 μg) and pancuronium (0.5 mg) in IVRA 3. They 
obtained successful analgesia in 100% of the cases with 
the combination of lidocaine, fentanyl and pancuronium in 
comparison with only 27% with the combination of lidocaine, 
fentanyl and only 13% with lidocaine alone 3. In our study, 
we compared the combination of fentanyl (0.05 mg), vecu-
ronium (0.5 mg) and 0.25% lidocaine (100 mg) with the 0.5% 
lidocaine (200 mg) and noted 100% successful anesthesia 
in both the groups. Thus, we obtained the same quality of 
anesthesia as traditional high dose of lidocaine by using a 
combination of a nontoxic dose of lidocaine, low dose of 
vecuronium and fentanyl. As with the conventional method, 
the duration of postoperative analgesia was much less, even 
with the addition of fentanyl. 
There were no signiﬁ cant side effects either group du-
ring intraoperative period. In the post tourniquet deﬂ ation 
period in the 0.5% lidocaine only group, patients showed 
signiﬁ cant incidence of giddiness that was not seen in any 
other group. This shows that a combination of opioid and 
muscle relaxants with low-dose lidocaine signiﬁ cantly redu-
ces the incidence of potential local anesthetic toxicity. In 
addition, Abdulla and Fadhil had conﬁ rmed the safety of a 
combined solution of 100 mg lidocaine, 0.05 mg of fentanyl 
and 0.5 mg pancuronium, with the absence of side effects, 
by releasing the tourniquet pressure soon after administering 
the solution above 3. 
The precise role of opioid or muscle relaxant in IVRA 
is not clear. Opioid may possibly produce some degree of 
suppression of neural conduction and this may potentiate 
the effect of local anesthetic in IVRA 3. Muscle relaxant may 
potentiate the local anesthetic by blocking muscle spindle 
activity, thus reducing muscle tone and spasm 2,4,5.
In conclusion, both solutions can be used safely and 
effectively in intravenous regional anesthesia for upper limb 
orthopedic surgery. The addition of fentanyl and vecuronium 
to lidocaine helps in reducing lidocaine dose and, thus, 
lessening the potential local anesthetic toxicity in IVRA. 
The combined solution of fentanyl, vecuronium and 0.25% 
lidocaine has slower onset of sensory and motor block but it 
will not clinically delay the starting time of surgery.
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